Medifast MED Investing Cash Flow
Investing Cash Flow at other companies
Other financials
Where this comes from
Reported directly by Medifast in its filing.
Tagged under the XBRL concept us-gaap:NetCashProvidedByUsedInInvestingActivities.
The official record: Medifast’s 10-Q, filed May 4, 2026, on SEC EDGAR. View the filing →
Ask your AI about Medifast's investing cash flow.
Connect your AI assistant and compare it to peers, right in your chat.
Connect your AI

Claude
Questions, answered.
- What is Medifast's investing cash flow?
- Medifast (MED) reported investing cash flow of -$17.13M in Q1 2026.
- How has Medifast's investing cash flow changed year-over-year?
- Medifast's investing cash flow decreased by 734.1% year-over-year, from -$2.05M to -$17.13M.
- What is the long-term trend for Medifast's investing cash flow?
- Over 3 years (2021 to 2025), Medifast's investing cash flow has grown at a -35.1% compound annual growth rate (CAGR), from -$29.06M to -$7.93M.
- What does investing cash flow mean?
- Total net cash provided by or used in investing activities — capex, acquisitions, investment purchases/sales, and other investing items.